PL445978A1 - Koniugaty kwasów hydroksycynamonowych i 9-amino-5,11-dimetylo-5H-indolo[2,3- b]chinoliny, sposób ich otrzymywania, zastosowanie medyczne oraz kompozycja farmaceutyczna - Google Patents

Koniugaty kwasów hydroksycynamonowych i 9-amino-5,11-dimetylo-5H-indolo[2,3- b]chinoliny, sposób ich otrzymywania, zastosowanie medyczne oraz kompozycja farmaceutyczna

Info

Publication number
PL445978A1
PL445978A1 PL445978A PL44597823A PL445978A1 PL 445978 A1 PL445978 A1 PL 445978A1 PL 445978 A PL445978 A PL 445978A PL 44597823 A PL44597823 A PL 44597823A PL 445978 A1 PL445978 A1 PL 445978A1
Authority
PL
Poland
Prior art keywords
indolo
quinoline
dimethyl
amino
obtaining
Prior art date
Application number
PL445978A
Other languages
English (en)
Other versions
PL248245B1 (pl
Inventor
Olga Michalak
Katarzyna Sidoryk
Marcin Cybulski
Marek Kubiszewski
Joanna TOBIASZ
Anna Jaromin
Magdalena Zaremba-Czogalla
Original Assignee
Sieć Badawcza Łukasiewicz - Instytut Chemii Przemysłowej Imienia Profesora Ignacego Mościckiego
Uniwersytet Wrocławski We Wrocławiu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sieć Badawcza Łukasiewicz - Instytut Chemii Przemysłowej Imienia Profesora Ignacego Mościckiego, Uniwersytet Wrocławski We Wrocławiu filed Critical Sieć Badawcza Łukasiewicz - Instytut Chemii Przemysłowej Imienia Profesora Ignacego Mościckiego
Priority to PL445978A priority Critical patent/PL248245B1/pl
Publication of PL445978A1 publication Critical patent/PL445978A1/pl
Publication of PL248245B1 publication Critical patent/PL248245B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Przedmiotem zgłoszenia są nowe amidowe koniugaty kwasu hydroksycynamonowego lub jego pochodnej oraz 9-amino-5,11-dimetylo-5H-indolo[2,3-b]chinoliny, inaczej nowe pochodne N-(hydroksy)cynamoilo-9-amino-5,11-dimetylo-5H-indolo[2,3-b]chinoliny, przedstawione wzorem I, w którym R-C(O)- oznacza grupę acylową pochodzącą od kwasu hydroksycynamonowego lub jego pochodnej oraz ich farmaceutycznie dopuszczalne sole. Wynalazkiem jest również sposób otrzymywania określonych powyżej nowych związków hybrydowych, a także ich zastosowanie medyczne oraz zawierająca je kompozycja farmaceutyczna. Otrzymane nowe pochodne o strukturze hybrydowej mogą być stosowane jako substancje aktywne w kompozycjach farmaceutycznych przeznaczonych do leczenia nowotworów.
PL445978A 2023-08-31 2023-08-31 Koniugaty kwasów hydroksycynamonowych i 9-amino-5,11-dimetylo-5H-indolo[2,3-b]chinoliny, sposób ich otrzymywania, zastosowanie medyczne oraz kompozycja farmaceutyczna PL248245B1 (pl)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL445978A PL248245B1 (pl) 2023-08-31 2023-08-31 Koniugaty kwasów hydroksycynamonowych i 9-amino-5,11-dimetylo-5H-indolo[2,3-b]chinoliny, sposób ich otrzymywania, zastosowanie medyczne oraz kompozycja farmaceutyczna

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL445978A PL248245B1 (pl) 2023-08-31 2023-08-31 Koniugaty kwasów hydroksycynamonowych i 9-amino-5,11-dimetylo-5H-indolo[2,3-b]chinoliny, sposób ich otrzymywania, zastosowanie medyczne oraz kompozycja farmaceutyczna

Publications (2)

Publication Number Publication Date
PL445978A1 true PL445978A1 (pl) 2025-03-03
PL248245B1 PL248245B1 (pl) 2025-11-12

Family

ID=94771197

Family Applications (1)

Application Number Title Priority Date Filing Date
PL445978A PL248245B1 (pl) 2023-08-31 2023-08-31 Koniugaty kwasów hydroksycynamonowych i 9-amino-5,11-dimetylo-5H-indolo[2,3-b]chinoliny, sposób ich otrzymywania, zastosowanie medyczne oraz kompozycja farmaceutyczna

Country Status (1)

Country Link
PL (1) PL248245B1 (pl)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008062466A2 (en) * 2006-10-13 2008-05-29 Reliance Life Sciences Pvt. Ltd. Cinnamic acid, vanillic acid and benzofuran derivatives for use in the treatment of inflammation and cancer
WO2015147666A1 (en) * 2014-03-28 2015-10-01 Instytut Farmaceutyczny N-guanyl derivatives of 9-amino-5.1 1 -dimethyl-5h-indolo[2,3-b]quinoline having cytotoxic activity
US10233183B1 (en) * 2018-07-18 2019-03-19 Shaanxi University Of Science And Technology 13-hydroxysparteine cinnamic acid derivatives with anti-tumor activities and a method of preparing the same

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008062466A2 (en) * 2006-10-13 2008-05-29 Reliance Life Sciences Pvt. Ltd. Cinnamic acid, vanillic acid and benzofuran derivatives for use in the treatment of inflammation and cancer
WO2015147666A1 (en) * 2014-03-28 2015-10-01 Instytut Farmaceutyczny N-guanyl derivatives of 9-amino-5.1 1 -dimethyl-5h-indolo[2,3-b]quinoline having cytotoxic activity
US10233183B1 (en) * 2018-07-18 2019-03-19 Shaanxi University Of Science And Technology 13-hydroxysparteine cinnamic acid derivatives with anti-tumor activities and a method of preparing the same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
KATARZYNA SIDORYK I IN.: "Molecules 2020, 25, 3470", „SYNTHESIS OF THIOL DERIVATIVES OF BIOLOGICAL ACTIVE COMPOUNDS FOR NANOTECHNOLOGY APPLICATION" *

Also Published As

Publication number Publication date
PL248245B1 (pl) 2025-11-12

Similar Documents

Publication Publication Date Title
US9775818B2 (en) Methods for treating bacterial infections
ES2558685T3 (es) Uso de compuestos de pirroloquinolina para eliminar microorganismos clínicamente latentes
HRP20120494T1 (hr) Derivati purina za uporabu kao agonista adenozin a2a receptora
EP4491199A3 (en) Gadolinium bearing pcta-based contrast agents
PH12022550156A1 (en) Substituted 2-morpholinopyridine derivatives as atr kinase inhibitors
PH12021551256A1 (en) Pantetheine derivatives and uses thereof
ES2542206T3 (es) Medicamentos que contienen fluoroquinolonas
MA31685B1 (fr) Nouveaux derives de 6-triazolopyridazine-sulfanyl benzothiazole et benzimidazole, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteurs de met
CY1113269T1 (el) Παραγωγα ινδαζολυλ αμιδιου για τη θεραπευτικη αγωγη διαταραχων διαμεσολαβουμενων υπο υποδοχεα γλυκοκορτικοειδων
JP5982016B2 (ja) 炎症性疾患の治療に使用されるｎ−アシルエタノールアミンに対して特異的なアミダーゼを調節する組成物及び方法
BR122021000304B1 (pt) Composto, uso do mesmo e composição farmacêutica antibacteriana
BR112014019478A2 (pt) composto ou um sal farmacologicamente aceitável do mesmo, composição farmacêutica, uso de um composto ou de um sal farmacologicamente aceitável do mesmo, formulação inibidor do canal de sódio, métodos para tratamento e/ou prevenção de dor e de uma doença.
EA201592055A1 (ru) 11-гидроксилпроизводные желчных кислот и их аминокислотные конъюгаты в качестве модуляторов фарнезоидных х-рецепторов
BG93979A (bg) Производни на n-(4-пиперидинил)(дихидробензофуран или дихидро-2н-бензопиран)карбоксамид, фармацевтичен състав, който ги съдържа, метод за получаване на производните и приложението им
ES2672468T3 (es) Momelotinib deuterado
ES2912327T3 (es) Composición acuosa oftálmica
FR2903107B1 (fr) Derives d'imidazopyridine-2-carboxamides, leur preparation et leur application en therapeutique
BR0309305A (pt) Compostos de imidazol como agentes antiinflamatórios e analgésicos
BR0309188A (pt) Compostos pirazolo como agentes antiinflamatórios e analgésicos
ZA202308600B (en) Methods and pharmaceutical composition for treating diseases
SE0402925D0 (sv) Novel Compounds
MY206262A (en) Macrocyclic tyrosine kinase inhibitor and uses thereof
EA201992090A1 (ru) ДЕЙТЕРИРОВАННЫЕ СОЕДИНЕНИЯ ИМИДАЗО[4,5-c]ХИНОЛИН-2-ОНА И ИХ ПРИМЕНЕНИЕ В ЛЕЧЕНИИ РАКА
MX2019003470A (es) Composicion farmaceutica y metodo para el tratamiento de la enfermedad del higado graso no alcoholico.
MX2022011242A (es) Inmunomodulación de o-het/aril azálidos.